Meridian Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-49,600
Closed -$169K 205
2018
Q3
$169K Hold
49,600
0.07% 166
2018
Q2
$186K Hold
49,600
0.09% 179
2018
Q1
$203K Buy
+49,600
New +$203K 0.1% 171